Regen Biopharma begins audit of FY2020 financials to cure reporting delinquency

Regen BioPharma Inc

BF Borgers CPA PC started audit of FY2020 financial statements on July 8, 2021.
Audit is a step towards filing overdue Form 10-K for fiscal year ended September 30, 2020.
Borgers also audited FY2019 and FY2018 statements for the company.

item 8.01

Regen BioPharma Inc filing history →

Source: SEC EDGAR

accession 0001607062-21-000214

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.